Eric Gratias, MD, FAAP

Research Reports

Oncology Pathways Drive Adoption of High-Quality Treatment Regimens and Deliver Drug Cost Savings

08/07/2023

Robinson Ortiz , MD;

Rama Al Ghannam , PharmD;

Stephen Hamilton , MD;

Timothy Dollear , MD, MS;

Kathryn Christensen , MD, MS;

Eric Gratias , MD, FAAP;

Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.

Kathryn Christensen, MS, and...

08/07/2023

Journal of Clinical Pathways

Research Reports

08/15/2022

Kathryn Christensen , MD, MS;

Timothy Dollear , MD, MS;

Eric Gratias , MD, FAAP;

Christopher Linkimer , CPA;

Margaret Rausa , PharmD;

Nick Andrews , PharmD;

Stephen Hamilton , MD;

Dr Hamilton and colleagues outline how eviCore Healthcare offered the option for payer clients to implement a biosimilar preferencing policy, analyzing how this policy affected the rate of biosimilar use and costs.

Dr Hamilton and colleagues...

08/15/2022

Journal of Clinical Pathways

Research Reports

Use of Clinical Decision Support and Peer Review to Increase NCCN Guideline Adherence

02/18/2020

Margaret Rausa , PharmD;

Stephen Hamilton , MD;

David Spangler ;

Eric Gratias , MD, FAAP;

Abstract: eviCore healthcare uses the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®) to support its proprietary program for medical oncology drug management. The...

...

02/18/2020

Journal of Clinical Pathways